HCID 67157181, compound → HCID 67157135, compound
Reaction equation
[C:1]1([CH:7]([CH3:29])[CH2:8]/[CH:9]=[CH:10]\[C:11]2[N:12]=[C:13]([CH:16]3[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:18][CH2:17]3)[S:14][CH:15]=2)[CH:6]=[CH:5][CH:4]=[CH:3][CH:2]=1>CO.[Pd]>[C:1]1([CH:7]([CH3:29])[CH2:8][CH2:9][CH2:10][C:11]2[N:12]=[C:13]([CH:16]3[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:18][CH2:17]3)[S:14][CH:15]=2)[CH:2]=[CH:3][CH:4]=[CH:5][CH:6]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
tert-Butyl 4-{4-[(1Z)-4-phenylpent-1-en-1-yl]-1,3-thiazol-2-yl}piperidine-1-carboxylate (IV-4, 1.00 g) is dissolved in methanol and, at 40° C., hydrogenated under an H2-pressure of 10 bar in the presence of Pd/C (10%) for 5 hours. Filtration and removal of the solvent under reduced pressure gives tert-butyl 4-[4-(4-phenylpentyl)-1,3-thiazol-2-yl]piperidine-1-carboxylate (1.00 g) as a colourless oil. This is deprotected analogously to Example II-2. This gives 850 mg of 4-[4-(4-phenylpentyl)-1,3-thiazol-2-yl]piperidine hydrochloride. 169 mg are then reacted analogously to Example I-81 with [5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetic acid (100 mg). After chromatographic purification, this gives 2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]-1-{4-[4-(4-phenylpentyl)-1,3-thiazol-2-yl]piperidin-1-yl}ethanone (180 mg) as a colourless oil.
Workup
- customfor 5 hours
- filtrationFiltration and removal of the solvent under reduced pressure
Sources & evidence
- ORD record
- ord-20b00cacf4bc4211a71e6eafea8a6c61
- Source dataset
- uspto-grants-2011_05
- Patent number
- US07943774B2
Reaction notes
Loading…